Latvian
Atlasīt vietnes valodu

Spironolactone Ceva (spironolactone) – Conditions or restrictions regarding supply and use - QC03DA01

Updated on site: 09-Feb-2018

Zāļu nosaukums: Spironolactone Ceva
ATĶ: QC03DA01
Viela: spironolactone
Ražotājs: Ceva Sante Animale
LatvianLatvian
Mainīt valodu

A.MANUFACTURER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer responsible for batch release

Ceva Santé Animale Z.I. Très le Bois 22600 Loudéac France

Catalent Germany

Schorndorf GmbH

Steinbeistrasse 2

D-73614 Schorndorf

Germany

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Veterinary medicinal product subject to prescription.

C.STATEMENT OF THE MRLs

Not applicable.

D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION

Ceva Santé Animale ensures that the system of pharmacovigilance, as described in Part I of the marketing authorisation application, is in place and functioning before and whilst the veterinary medicinal product is on the market.

Komentārus